Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Menopause01:28

Menopause

5.0K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.0K
Oogenesis02:07

Oogenesis

58.1K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
58.1K
Oogenesis01:22

Oogenesis

5.0K
Oogenesis,  the process of developing egg cells (female gametes), occurs within the ovaries and is fundamental to female fertility. This sequence begins during fetal development when diploid oogonia in the developing ovaries undergo mitotic divisions to produce primary oocytes. By birth, these primary oocytes enter prophase I of meiosis but become arrested in this stage, remaining suspended until puberty.
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is...
5.0K
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

2.4K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
2.4K
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

4.5K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
4.5K
Signs of Puberty01:27

Signs of Puberty

2.1K
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Black Hole Spectroscopy and Tests of General Relativity with GW250114.

Physical review letters·2026
Same author

Selection of human embryo for IVF treatment using ensemble machine learning technique.

Morphologie : bulletin de l'Association des anatomistes·2025
Same author

GW250114: Testing Hawking's Area Law and the Kerr Nature of Black Holes.

Physical review letters·2025
Same author

Neoadjuvant Chemotherapy and Low Dose Immunotherapy in Resectable Non-small Cell Lung Cancer: A Multi-center Retrospective Cohort Analysis.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

Estimating Ground Reaction Forces From Inertial Sensors.

IEEE transactions on bio-medical engineering·2024
Same author

Publisher Correction: Live-cell three-dimensional single-molecule tracking reveals modulation of enhancer dynamics by NuRD.

Nature structural & molecular biology·2023

Related Experiment Video

Updated: Apr 28, 2026

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
14:26

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice

Published on: April 7, 2014

16.6K

Premature menopause - Meeting the needs.

D Shah1, N Nagarajan2

  • 1Gynaecworld, The Center for Women's Health and Fertility, Mumbai, Maharashtra, India durushah@gmail.com.

Post Reproductive Health
|June 1, 2014
PubMed
Summary
This summary is machine-generated.

Premature menopause, or primary ovarian insufficiency, affects women under 40. Management involves hormone therapy and assisted reproduction for fertility, with oocyte cryopreservation for anticipated cases.

Keywords:
Cryopreservationmenopausal hormone therapyoocyte donationoocyte/embryo freezing/vitrificationpremature ovarian insufficiency

More Related Videos

Z-Scores for Assessing Ovarian Reserve in Young Patients Undergoing Fertility Preservation
05:42

Z-Scores for Assessing Ovarian Reserve in Young Patients Undergoing Fertility Preservation

Published on: October 25, 2024

1.5K
Cell-Specific Paired Interrogation of the Mouse Ovarian Epigenome and Transcriptome
12:25

Cell-Specific Paired Interrogation of the Mouse Ovarian Epigenome and Transcriptome

Published on: February 24, 2023

1.5K

Related Experiment Videos

Last Updated: Apr 28, 2026

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
14:26

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice

Published on: April 7, 2014

16.6K
Z-Scores for Assessing Ovarian Reserve in Young Patients Undergoing Fertility Preservation
05:42

Z-Scores for Assessing Ovarian Reserve in Young Patients Undergoing Fertility Preservation

Published on: October 25, 2024

1.5K
Cell-Specific Paired Interrogation of the Mouse Ovarian Epigenome and Transcriptome
12:25

Cell-Specific Paired Interrogation of the Mouse Ovarian Epigenome and Transcriptome

Published on: February 24, 2023

1.5K

Area of Science:

  • Reproductive Endocrinology
  • Genetics
  • Women's Health

Background:

  • Premature menopause (primary ovarian insufficiency) is defined as amenorrhea and sex steroid deficiency in women under 40.
  • Causes are diverse, including spontaneous factors and iatrogenic treatments, with X chromosomal abnormalities being a primary genetic cause.
  • This condition leads to estrogen deficiency, infertility, and increased risk of cardiovascular disease, Alzheimer's disease, and osteoporosis.

Approach:

  • Review of current understanding of premature ovarian insufficiency etiology and clinical presentation.
  • Discussion of management strategies including hormone replacement therapy and assisted reproductive technologies.
  • Emphasis on the role of assisted reproductive technologies like in vitro fertilization (IVF) with donor oocytes and oocyte/embryo cryopreservation.

Key Points:

  • Primary ovarian insufficiency presents with irregular cycles, amenorrhea, estrogen deficiency symptoms, and infertility.
  • Women with POI face elevated risks for significant non-communicable diseases.
  • Hormonal management until the natural age of menopause is crucial.
  • In vitro fertilization (IVF) using donor eggs offers the best fertility outcomes.
  • Oocyte and embryo cryopreservation are vital for preserving fertility when POI is anticipated.

Conclusions:

  • Effective management of premature menopause requires a personalized approach combining hormone therapy and advanced reproductive interventions.
  • Utilizing assisted reproductive technologies, particularly oocyte cryopreservation, is essential for women facing fertility challenges due to impending primary ovarian insufficiency.
  • Early diagnosis and intervention are key to mitigating long-term health risks associated with premature ovarian insufficiency.